Related Experiment Videos
Supraventricular tachycardia in pregnancy
1Department of Obstetric Anaesthesia, St James' University Hospital, Beckett Street, Leeds LS9 7TF, UK. kayrobins14@hotmail.com
British Journal of Anaesthesia
|December 11, 2003
Summary
Supraventricular tachycardia (SVT) in pregnancy can have various causes. Adenosine is recommended as the primary treatment, with anesthetic management options discussed for different stages of pregnancy and delivery.
Area of Science:
- Cardiology
- Obstetrics
- Anesthesiology
Background:
- Supraventricular tachycardia (SVT) is a significant concern in pregnancy.
- Understanding the varied etiologies of SVT during gestation is crucial for effective management.
Observation:
- This study details four cases of SVT in pregnant patients.
- The cases presented diverse underlying causes for the arrhythmias.
Findings:
- Risk factors contributing to SVT development in pregnancy were identified.
- Optimal obstetric anesthetic management strategies for SVT during pregnancy, labor, and Cesarean section were explored.
- Adenosine emerged as the recommended first-line pharmacologic therapy.
Implications:
- This research provides guidance for managing SVT in pregnant individuals.
- It highlights the importance of tailored anesthetic approaches for parturient women with SVT.
- The findings support the use of adenosine for acute SVT episodes in pregnancy.